Keeps Biopharma Statistics

Total Valuation

Keeps Biopharma has a market cap or net worth of KRW 304.84 billion. The enterprise value is 358.15 billion.

Market Cap	304.84B
Enterprise Value	358.15B

Important Dates

The last earnings date was Monday, May 12, 2025.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

Keeps Biopharma has 19.08 million shares outstanding. The number of shares has increased by 0.38% in one year.

Current Share Class	19.08M
Shares Outstanding	19.08M
Shares Change (YoY)	+0.38%
Shares Change (QoQ)	+2.90%
Owned by Insiders (%)	4.34%
Owned by Institutions (%)	0.86%
Float	13.92M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.23
PB Ratio	4.35
P/TBV Ratio	30.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 87.71, with an EV/FCF ratio of -35.19.

EV / Earnings	-49.14
EV / Sales	2.62
EV / EBITDA	87.71
EV / EBIT	260.77
EV / FCF	-35.19

Financial Position

The company has a current ratio of 0.98, with a Debt / Equity ratio of 0.89.

Current Ratio	0.98
Quick Ratio	0.51
Debt / Equity	0.89
Debt / EBITDA	11.19
Debt / FCF	-6.15
Interest Coverage	0.63

Financial Efficiency

Return on equity (ROE) is -4.22% and return on invested capital (ROIC) is 1.48%.

Return on Equity (ROE)	-4.22%
Return on Assets (ROA)	1.17%
Return on Invested Capital (ROIC)	1.48%
Return on Capital Employed (ROCE)	2.96%
Revenue Per Employee	4.40B
Profits Per Employee	-235.10M
Employee Count	31
Asset Turnover	0.88
Inventory Turnover	7.89

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +141.03% in the last 52 weeks. The beta is 1.33, so Keeps Biopharma's price volatility has been higher than the market average.

Beta (5Y)	1.33
52-Week Price Change	+141.03%
50-Day Moving Average	11,814.40
200-Day Moving Average	7,583.45
Relative Strength Index (RSI)	61.72
Average Volume (20 Days)	1,381,108

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Keeps Biopharma had revenue of KRW 136.52 billion and -7.29 billion in losses. Loss per share was -387.97.

Revenue	136.52B
Gross Profit	20.20B
Operating Income	2.88B
Pretax Income	-1.07B
Net Income	-7.29B
EBITDA	5.59B
EBIT	2.88B
Loss Per Share	-387.97

Full Income Statement

Balance Sheet

The company has 24.08 billion in cash and 62.59 billion in debt, giving a net cash position of -38.51 billion or -2,018.64 per share.

Cash & Cash Equivalents	24.08B
Total Debt	62.59B
Net Cash	-38.51B
Net Cash Per Share	-2,018.64
Equity (Book Value)	70.06B
Book Value Per Share	2,928.20
Working Capital	-1.34B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -3.16 billion and capital expenditures -7.02 billion, giving a free cash flow of -10.18 billion.

Operating Cash Flow	-3.16B
Capital Expenditures	-7.02B
Free Cash Flow	-10.18B
FCF Per Share	-533.49

Full Cash Flow Statement

Margins

Gross margin is 14.80%, with operating and profit margins of 2.11% and -5.34%.

Gross Margin	14.80%
Operating Margin	2.11%
Pretax Margin	-0.78%
Profit Margin	-5.34%
EBITDA Margin	4.10%
EBIT Margin	2.11%
FCF Margin	n/a

Dividends & Yields

Keeps Biopharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.38%
Shareholder Yield	n/a
Earnings Yield	-2.39%
FCF Yield	-3.34%

Stock Splits

The last stock split was on May 20, 2020. It was a forward split with a ratio of 3.

Last Split Date	May 20, 2020
Split Type	Forward
Split Ratio	3

Scores

Keeps Biopharma has an Altman Z-Score of 1.48. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.48
Piotroski F-Score	n/a